For release at 7.00 am on Thursday 1st October 2015
Johnson Matthey completes sale of Research Chemicals (Alfa Aesar) business to Thermo Fisher Scientific Inc.
Johnson Matthey, a global leader in sustainable technologies, announces that on 30th September 2015 it completed the sale of its Alfa Aesar Research Chemicals business to Thermo Fisher Scientific Inc. for £256 million in cash. This completes the transaction which was first announced on 25th June 2015.
Commenting on the transaction, Robert MacLeod, Chief Executive of Johnson Matthey said: "The divestment of the Research Chemicals business is a further step in delivering our long term strategy to focus the group on growth areas where we can apply our expertise in complex chemistry to create long term value for our shareholders."
About Johnson Matthey
Johnson Matthey is a global speciality chemicals company underpinned by science, technology and its people. A leader in sustainable technologies, many of the group's products enhance the quality of life of millions through their beneficial impact on the environment, human health and wellbeing. The group focuses on clean air, clean energy and low carbon technologies and is an expert in the application and recycling of precious metals. Johnson Matthey has operations in over 30 countries and employs around 13,000 people. Its products and services are sold across the world to a wide range of advanced technology industries. For further information, please visit www.matthey.com.
Enquiries:
|
|
|
Sally Jones |
Director, IR and Corporate Communications |
+44 20 7269 8407 |
David Allchurch |
Tulchan Communications |
+44 20 7353 4200 |
www.matthey.com |
|
|